Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. O’Donnell J TL, Gladden RM, Davis NL, Bitting J. Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls — United States, 2019–2020. MMWR Morb Mortal Wkly Rep. 2021;70:1740-1746. https://doi.org/10.15585/mmwr.mm7050e3
2. Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerdá M. Has the treatment gap for opioid use disorder narrowed in the U.S.?: a yearly assessment from 2010 to 2019. Int J Drug Policy. 2022:103786. https://doi.org/10.1016/j.drugpo.2022.103786
3. National Academies of Sciences, Engineering, Medicine. Methadone Treatment for Opioid Use Disorder: Improving Access through Regulatory and Legal Change: Proceedings of a Workshop. The National Academies Press; 2022:180.
4. Simon C, Vincent L, Coulter A, et al. The Methadone Manifesto: treatment experiences and policy recommendations from methadone patient activists. Am J Public Health. 2022;112(S2):S117-s122. https://doi.org/10.2105/ajph.2021.306665
5. Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Guarino H. "It's like 'liquid handcuffs": the effects of take-home dosing policies on methadone maintenance treatment (MMT) patients' lives. Harm Reduct J. 2021;18(1):88. https://doi.org/10.1186/s12954-021-00535-y
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献